Progressive multifocal leukoencephalopathy during treatment with lenalidomide and elotuzumab for multiple myeloma.

Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease of the central nervous system caused by the reactivation of the John Cunningham virus (JCV) [1]. PML is commonly o...